Author

Nathan H. Vande Burgt

Observed names: Nathan H Vande Burgt, Nathan Vande Burgt

Institutions: Oregon Health & Science University, Vaccine and Gene Therapy Institute

Observed institutions: University College Dublin, Oregon National Primate Research Center, Oregon Health & Science University, Vaccine and Gene Therapy Institute, University of Pennsylvania

ORCID: 0000-0001-6311-9082

Observed ORCID: 0000-0001-6311-9082

OpenAlex ID: A5023964866

Agricultural anaerobic digestion power plants in Ireland and Germany: policy and practice

2016 · Agathe Auer, Nathan H Vande Burgt, et al. · Journal of the Science of Food and Agriculture · 37

Chinese hamster ovary cell lines selected for resistance to ebolavirus glycoprotein mediated infection are defective for NPC1 expression

2012 · Kathleen M. Haines, Nathan H. Vande Burgt, et al. · Virology · 32

Requirements within the Ebola Viral Glycoprotein for Tetherin Antagonism

2015 · Nathan Vande Burgt, Rachel Kaletsky, et al. · Viruses · 25

Comparison of in vitro viability methods for Cryptosporidium oocysts

2018 · Nathan H. Vande Burgt, Agathe Auer, et al. · Experimental Parasitology · 15

Rhesus Cytomegalovirus-encoded Fcγ-binding glycoproteins facilitate viral evasion from IgG-mediated humoral immunity

2025 · Claire E. Otero, Sophia Petkova, et al. · Nature Communications · 11

Late gene expression–deficient cytomegalovirus vectors elicit conventional T cells that do not protect against SIV

2023 · Scott G. Hansen, Jennie L. Womack, et al. · JCI Insight · 11

Ebola virus mediated infectivity is restricted in canine and feline cells

2015 · Ziying Han, Stephen M. Bart, et al. · Veterinary Microbiology · 10

The pentameric complex is not required for congenital CMV transmission in seronegative rhesus macaques

2025 · Hsuan-Yuan Wang, Husam Taher, et al. · Science Translational Medicine · 9

HIV-1 Virus-like Particle Budding Assay

2013 · Nathan Vande Burgt, Luis Cocka, et al. · BIO-PROTOCOL

Works count: 9

Citation count: 150

H-index: 8

I10-index: 7